2025 Strategic Guide to the Dry Eye Medication Market – Forecasts and Business Use Cases

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts

 
 What is the projected market size of the dry eye medication industry, and what is its expected CAGR?
 The dry eye medication market size has grown rapidly in recent years. It will grow from $11.01 billion in 2024 to $12.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to aging population, rising number of contact lens users, increase in disposable income, increase in number of treatment options, increase in number of allergies, rise in consumption of unhealthy or improper diets, and prevalence of diabetes mellitus.
 
 The dry eye medication market size is expected to see rapid growth in the next few years. It will grow to $18.71 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease, and side effects of other medications. Major trends in the forecast period include developing preservative-free eye drops, investing in research and development of new and advanced drugs, developing innovative drugs to survive in the market, developing non-steroidal anti-inflammatory ophthalmic drugs for the treatment of dry-eye syndrome, focusing on incorporating modern techniques, and developing combination therapies for the treatment of dry eye diseases.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp
 
 What external factors are influencing the dry eye medication market’s growth momentum?
 The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely. For example, a survey conducted by the American Academy of Ophthalmology reported that in the USA, nearly 3.2 million women and 1.68 million men, over the age of 50 were affected by dry eye syndrome. Similarly, a study conducted by the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in the Northern part of India. the rising prevalence of the disease would increase the demand for its treatment and ultimately facilitate the growth of the dry eye medication market.
 
 What are the major market segments driving the growth of the dry eye medication industry?
 The dry eye medication market covered in this report is segmented –
 
 1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative
 2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System
 3) By Prescription Type: OTC Drugs, Prescription Drugs
 4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies
 
 Subsegments:
 1) By Aqueous: Artificial Tears (lubricating eye drops), Prescription Eye Drops, Ophthalmic Solutions
 2) By Evaporative: Punctal Plugs (to reduce tear drainage), Lipid-Based Eye Drops, Eye Ointments (with lipid components)
 3) By Aqueous and Evaporative: Combination Eye Drops (formulated to address both aqueous And evaporative dry eye), Multi-Action Eye Care Products
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report
 
 What future trends will impact the direction of the dry eye medication industry?
 Major companies operating in the dry eye medication market are developing innovative products, such as Cyclosporine ophthalmic solutions, to stimulate tear production, reduce ocular inflammation, and provide long-term relief. Cyclosporine ophthalmic solutions are prescription eye drops containing the immunosuppressant cyclosporine, used primarily to treat dry eye disease by increasing tear production and reducing inflammation in the eyes. For instance, in June 2023, Novaliq GmbH, a Germany-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for VEVYE (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. VEVYE (development name CyclASol) is the first and only cyclosporine solution specifically approved for treating the signs and symptoms of dry eye disease, showing efficacy within just four weeks of treatment. Formulated with a novel, water-free excipient, VEVYE addresses unmet patient needs by offering a fast-acting and well-tolerated therapy for dry eyes. Unlike traditional solutions, it is free from water, anti-microbial preservatives, oils, and surfactants, which eliminates concerns related to pH and osmolarity.
 
 Who are the key market players contributing to the growth of the dry eye medication industry?
 Major companies operating in the dry eye medication market include Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Vision gain, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc, shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram.
 
 Which regions are leading the growth of the dry eye medication market globally?
 North America was the largest region in the market in 2024. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The Dry Eye Medication Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3807
 
 Need Customized Data On Dry Eye Medication Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=3807&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe — +44 7882 955267
 
 Asia: +91 88972 63534
 
 Americas — +1 310–496–7795
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company